Galafold Drug Insight Report, 2019: Drug Overview, Mechanism of Action, Clinical Trials, Regulatory Milestones, Deals, Partnerships, and Sales Forecasting to 2021 –

DUBLIN–(BUSINESS WIRE)–The “Galafold – Drug Insight, 2019” report has been added to’s offering.

Galafold – Drug Insight, 2019 report provides comprehensive information of the drug, Galafold.

It includes drugs overview, Galafold mechanism of action, clinical trials, regulatory milestones, deals & Galafold’s partnerships. It further provides Galafold`s patents (US & EU) and its API manufacturers details in the United States, Europe, China and India.

It also features the historical and forecasted Galafold sales till 2021. The report also throws light on Galafold market competition and emerging therapies in the same space as Galafold. Galafold SWOT analysis is also featured.

Scope of the Report

  • A comprehensive Galafold overview including product description, regulatory milestones, clinical trials, deals and partnerships, have been elaborated in this report
  • Galafold Patent information in United States (US) and Europe (EU) has been highlighted
  • Galafold API manufacturers in United States, Europe, China and India
  • The report contains historical and forecasted Galafold sales till 2021
  • Comprehensive coverage of the emerging therapies (Phase III) in the space where Galafold operates including their product description, research and development activities, collaborations and licensing deals, drug mechanism and chemical information
  • The report also features the Galafold SWOT analysis

Reasons to Buy

  • Establish a comprehensive understanding of the drug, Galafold
  • Access to Galafold API manufacturers details to devise API procurement strategy for generic development
  • Plan developmental timelines around Galafold patents for the major markets- US and EU
  • Understand current and future Galafold`s growth through its historical and forecasted sales
  • Identify and understand the current in-market competitors for Galafold
  • Identify the product attributes and use it for target finding, drug repurposing, and precision medicine
  • Identify and plan ahead for prospective emerging players and their products operating in the same space as Galafold
  • Identify opportunities in the same area as with Galafold SWOT analysis

Key Topics Covered

1. Report Introduction

2. Galafold – Overview

  • Galafold Product Description
  • Galafold Route of Synthesis
  • Galafold Mechanism of Action
  • Galafold Pharmacology
  • Galafold Pharmacodynamics
  • Galafold Pharmacokinetics
  • Galafold Adverse Reactions
  • Galafold Clinical Trials
  • Galafold Regulatory Milestones
  • Galafold Development Activities

3. Global API Manufacturers

  • United States
  • Europe
  • China
  • India

4. Product Details

5. Galafold Global Sales Assessment

  • Galafold Sales Global(Historical)
  • Galafold Sales Global(Forecasted)

6. Galafold Patent Details

7. Galafold Market Competition

8. Galafold Emerging Therapies

8.1. Drug name: Company name

  • Product Description
  • Research & Development
  • Product Development Activities

9. Galafold SWOT Analysis

List of Tables

Table 1: Galafold, Description

Table 2: API Manufacturers Region wise

Table 3: API Manufacturers for United States

Table 4: API Manufacturers for Europe

Table 5: API Manufacturers for China

Table 6: API Manufacturers for India

Table 7: Galafold Product Details, United States

Table 8: Galafold Product Details, Europe

Table 9: Galafold, Historical Global Sales till 2017 (in million USD)

Table 10: Galafold, Forecasted Global Sales from 2019-2021 (in million USD)

Table 11: Patent Details: Galafold

Table 12: Galafold Major Competitors

Table 13: Emerging Therapies

List of Figures

Figure 1: Galafold

Figure 2: Galafold, Historical Global Sales till 2017 (in million USD)

Figure 3: Galafold, Forecasted Global Sales from 2019-2021 (in million USD)

Figure 4: Patent Details: Galafold

Figure 5: API Manufacturers Region wise

For more information about this report visit

Source link